A Human Immune-on-Chip Platform for Preclinical Evaluation of Cancer Immunotherapies

Cancer immunotherapy relies on a coordinated sequence of events — immune cell activation, recruitment, tumour infiltration, and cytotoxic activity. Conventional in vitro assays investigate these steps in isolation, while animal models do not fully reproduce human-specific immune–tumour interactions.

In this poster, presented at IPLASS 2026, we demonstrate the versatility of the MIVO® organ-on-chip platform for investigating key mechanisms of antitumor immunity and evaluating cell-based and nanoparticle-enabled immunotherapeutic strategies under dynamic culture conditions — across three experimental configurations.

Highlights

  • Immune-on-chip with circulating NK cells: an alginate-based 3D neuroblastoma model was cultured in the MIVO® chamber while primary human NK cells circulated in the vascular compartment. Dynamic culture supported tumour-specific NK cell recruitment, extravasation, infiltration — and cytotoxic activity, inducing tumour cell apoptosis.
  • Dendritic cell-based immunotherapy: T cells primed by dendritic cells stimulated with MUC1-mimetic functionalized mannosylated peptide nanofibers showed enhanced tumour infiltration, increased IFN-γ release, and greater cytotoxicity against 3D breast cancer models.
  • Nanoparticle-loaded TILs: melanoma-derived TILs loaded with boron carbide nanoparticles preserved CXCR3-dependent chemotactic migration toward CXCL10 under physiological flow — maintaining their tumour-homing functionality after nanoparticle loading, a key requirement for combined adoptive cell therapy/nanomedicine strategies.

Take-Home Message

This human immune-on-chip platform recapitulates key steps of the cancer immunity cycle — immune-cell recruitment, extravasation, tumour infiltration, and cytotoxicity — under dynamic culture conditions, supporting mechanistic studies and preclinical assessment of cancer immunotherapies.

Conference: IPLASS 2026
Authors: Elisa Raboni1,2, Silvia Scaglione1,3, Elisabetta Palamà1, Maurizio Aiello1,3
1 React4Life S.p.A., Genoa (Italy) · 2 University of Genova, Genoa (Italy) · 3 National Research Council of Italy (CNR), Genoa (Italy)

1University of Genova, Genoa (Italy)
2React4life, Genoa (Italy)
3Consiglio Nazionale delle Ricerche (CNR)

Fill the form below to get your copy

Check your email! You will receive soon a message from us with the copy requested.


    Other Posters

    All Resources

    Never stop learning!

    Check publications from the team, protocols, and useful information to boost your research and get into organ on chip technology!

    Knowledge Hub